2022 World Conference on Lung Cancer (ePosters)-EP08.02-092. Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib

EP08.02-092. Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib

Pdf Summary

Summary Not Available

Asset Subtitle

Na Li

Meta Tag

Speaker Na Li

Topic Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments